Tamara A Seymour is Director of KEMPHARM, INC. Currently has a direct ownership of 719 shares of KMPH, which is worth approximately $3,551. The most recent transaction as insider was on Mar 17, 2023, when has been sold 519 shares (Common Stock) at a price of $4.82 per share, resulting in proceeds of $2,501. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 719
0% 3M change
0% 12M change
Total Value Held $3,551

TAMARA A SEYMOUR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2023
BUY
Open market or private purchase
$2,501 $4.82 p/Share
519 Added 41.92%
719 Common Stock
May 20 2022
BUY
Open market or private purchase
$974 $4.87 p/Share
200 Added 50.0%
200 Common Stock

Also insider at

ARTLW
ARTELO BIOSCIENCES, INC. Industrials
KTRA
Kintara Therapeutics, Inc. Healthcare
TAS

Tamara A Seymour

Director
San Diego, CA

Track Institutional and Insider Activities on KMPH

Follow KEMPHARM, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KMPH shares.

Notify only if

Insider Trading

Get notified when an Kempharm, Inc insider buys or sells KMPH shares.

Notify only if

News

Receive news related to KEMPHARM, INC

Track Activities on KMPH